Lansoprazole vs Tofacitinib
Lansoprazole vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Lansoprazole and Tofacitinib.
Mechanism of Action
Lansoprazole: Proton pump inhibitor.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Lansoprazole β 1.5 hours; Tofacitinib β 3.2 hours.
Chemical Properties
Molecular Formula: Lansoprazole β C16H14F3N3O2S; Tofacitinib β C16H20N6O.
Molecular Weight: Lansoprazole β 369.3620 g/mol; Tofacitinib β 312.3700 g/mol.
Type: Lansoprazole β Small molecule; Tofacitinib β Small molecule.